Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 484

1.

Prospective evaluation of visual function in patients with ocular diseases after robot-assisted laparoscopic prostatectomy.

Kakutani S, Asamoto M, Araki F, Chen YN, Shinokawa M, Okagami Y, Ohata T, Taguchi S, Yamada Y, Takeshima Y, Kume H, Yamada Y, Aihara M, Ito N, Fukuhara H.

Int J Urol. 2020 Feb 11. doi: 10.1111/iju.14183. [Epub ahead of print]

PMID:
32048341
2.

Paravesical space arteriovenous malformation as a specific subgroup of pelvic vascular anomaly: a case series and review of literature.

Kishino M, Nishida K, Kimura K, Takahashi M, Nakaminato S, Kume H, Uchiyama H, Kudo T, Kawada S, Mori K, Tateishi U.

Jpn J Radiol. 2020 Feb 10. doi: 10.1007/s11604-020-00924-6. [Epub ahead of print]

PMID:
32043235
3.
4.

Onychomadesis following pembrolizumab treatment for metastatic urothelial carcinoma: A report of two cases.

Sugihara Y, Kawai T, Yamada D, Furuyama C, Sato Y, Kume H.

Eur J Cancer. 2020 Feb;126:91-92. doi: 10.1016/j.ejca.2019.12.009. Epub 2020 Jan 7. No abstract available.

PMID:
31923731
5.

Structures and Inhibitory Activities for Interleukin-2 Production of Seasonally Variable Constituents in Flower Parts of Magnolia kobus at Different Growth Stages.

Oshima N, Kume H, Umeda T, Takito H, Tsukimoto M, Hada N.

Chem Pharm Bull (Tokyo). 2020;68(1):91-95. doi: 10.1248/cpb.c19-00611.

6.

TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.

Yamada Y, Kimura N, Takayama KI, Sato Y, Suzuki T, Azuma K, Fujimura T, Ikeda K, Kume H, Inoue S.

Cancer Sci. 2019 Dec 28. doi: 10.1111/cas.14295. [Epub ahead of print]

7.

Comprehensive epigenome characterization reveals diverse transcriptional regulation across human vascular endothelial cells.

Nakato R, Wada Y, Nakaki R, Nagae G, Katou Y, Tsutsumi S, Nakajima N, Fukuhara H, Iguchi A, Kohro T, Kanki Y, Saito Y, Kobayashi M, Izumi-Taguchi A, Osato N, Tatsuno K, Kamio A, Hayashi-Takanaka Y, Wada H, Ohta S, Aikawa M, Nakajima H, Nakamura M, McGee RC, Heppner KW, Kawakatsu T, Genno M, Yanase H, Kume H, Senbonmatsu T, Homma Y, Nishimura S, Mitsuyama T, Aburatani H, Kimura H, Shirahige K.

Epigenetics Chromatin. 2019 Dec 19;12(1):77. doi: 10.1186/s13072-019-0319-0.

8.

A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.

Enomoto Y, Namba Y, Hoshika Y, Komemushi Y, Mitani K, Kume H, Kobayashi E, Miyama Y, Homma Y, Ushiku T, Seyama K.

Eur J Med Genet. 2019 Nov 25:103820. doi: 10.1016/j.ejmg.2019.103820. [Epub ahead of print]

PMID:
31778855
9.

Insulin promotes sodium transport but suppresses gluconeogenesis via distinct cellular pathways in human and rat renal proximal tubules.

Nakamura M, Tsukada H, Seki G, Satoh N, Mizuno T, Fujii W, Horita S, Moriya K, Sato Y, Kume H, Nangaku M, Suzuki M.

Kidney Int. 2020 Feb;97(2):316-326. doi: 10.1016/j.kint.2019.08.021. Epub 2019 Sep 5.

PMID:
31735358
10.

Corrigendum to: Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.

Kume H, Homma Y, Shinohara N, Obara W, Kondo T, Kimura G, Fujimoto H, Nonomura N, Hongo F, Sugiyama T, Takahashi M, Kanayama HO, Fukumori T, Eto M.

Jpn J Clin Oncol. 2019 Dec 18;49(11):1067. doi: 10.1093/jjco/hyz143. No abstract available.

PMID:
31693139
11.

Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.

Senoh M, Kato H, Honda H, Fukuda T, Tagashira Y, Horiuchi H, Chiba H, Suzuki D, Hosokawa N, Kitazono H, Norisue Y, Kume H, Mori N, Morikawa H, Kashiwagura S, Higuchi A, Kato H, Nakamura M, Ishiguro S, Morita S, Ishikawa H, Watanabe T, Kojima K, Yokomaku I, Bando T, Toimoto K, Moriya K, Kasahara K, Kitada S, Ogawa J, Saito H, Tominaga H, Shimizu Y, Masumoto F, Tadera K, Yoshida J, Kikuchi T, Yoshikawa I, Watanabe T, Honda M, Yokote K, Toyokawa T, Miyazato H, Nakama M, Mahe C, Reske K, Olsen MA, Dubberke ER.

Anaerobe. 2019 Dec;60:102107. doi: 10.1016/j.anaerobe.2019.102107. Epub 2019 Oct 21.

PMID:
31647977
12.

Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids.

Kume H, Hojo M, Hashimoto N.

Front Pharmacol. 2019 Jul 25;10:765. doi: 10.3389/fphar.2019.00765. eCollection 2019.

13.

Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer.

Nozaki K, Kawai T, Fujimura T, Matsui H, Teshima T, Oshina T, Takahashi A, Sato Y, Yamada D, Azuma T, Hotta M, Nakajima K, Nakayama H, Minamimoto R, Kume H.

Int Urol Nephrol. 2019 Oct;51(10):1763-1769. doi: 10.1007/s11255-019-02233-y. Epub 2019 Jul 19.

PMID:
31325132
14.

Penile size and stretched rate in a Japanese male population: A cross-sectional cadaveric study.

Suzuki M, Ikegaya H, Idota N, Kawai T, Sato Y, Kume H.

Int J Urol. 2019 Sep;26(9):936-937. doi: 10.1111/iju.14052. Epub 2019 Jul 14. No abstract available.

PMID:
31304609
15.

Fluorescence Detection of Prostate Cancer by an Activatable Fluorescence Probe for PSMA Carboxypeptidase Activity.

Kawatani M, Yamamoto K, Yamada D, Kamiya M, Miyakawa J, Miyama Y, Kojima R, Morikawa T, Kume H, Urano Y.

J Am Chem Soc. 2019 Jul 3;141(26):10409-10416. doi: 10.1021/jacs.9b04412. Epub 2019 Jun 21.

PMID:
31244179
16.

Establishment of permutation for cancer risk estimation in the urothelium based on genome-wide DNA methylation analysis.

Tsumura K, Arai E, Tian Y, Shibuya A, Nishihara H, Yotani T, Yamada Y, Takahashi Y, Maeshima AM, Fujimoto H, Nakagawa T, Kume H, Homma Y, Yoshida T, Kanai Y.

Carcinogenesis. 2019 Nov 25;40(11):1308-1319. doi: 10.1093/carcin/bgz112.

PMID:
31241739
17.

Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patients.

Kawai T, Sato Y, Makino K, Yamada Y, Nomiya A, Nakamura M, Yamada D, Suzuki M, Igawa Y, Kume H.

Eur J Cancer. 2019 Jul;116:114-115. doi: 10.1016/j.ejca.2019.05.017. Epub 2019 Jun 10. No abstract available.

PMID:
31195355
18.

Robot-assisted radical prostatectomy versus volumetric modulated arc therapy: Comparison of front-line therapies for localized prostate cancer.

Taguchi S, Shiraishi K, Fujimura T, Naito A, Kawai T, Nakagawa K, Abe O, Kume H, Fukuhara H.

Radiother Oncol. 2019 Nov;140:62-67. doi: 10.1016/j.radonc.2019.05.015. Epub 2019 Jun 5.

PMID:
31176208
19.

Galectin-7 as a potential biomarker of Stevens-Johnson syndrome/toxic epidermal necrolysis: identification by targeted proteomics using causative drug-exposed peripheral blood cells.

Hama N, Nishimura K, Hasegawa A, Yuki A, Kume H, Adachi J, Kinoshita M, Ogawa Y, Nakajima S, Nomura T, Watanabe H, Mizukawa Y, Tomonaga T, Shimizu H, Abe R.

J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2894-2897.e7. doi: 10.1016/j.jaip.2019.05.002. Epub 2019 May 14. No abstract available.

PMID:
31100551
20.

Characteristics and association with survival of respiratory-related hospitalization in Japanese idiopathic pulmonary fibrosis patients.

Nishiyama O, Saeki S, Yamazaki R, Sano H, Iwanaga T, Kume H, Tohda Y.

Respir Investig. 2019 Sep;57(5):415-421. doi: 10.1016/j.resinv.2019.03.005. Epub 2019 Apr 16.

PMID:
31003952
21.

Longitudinal change of comprehensive lower urinary tract symptoms and various types of urinary incontinence during robot-assisted radical prostatectomy.

Fujimura T, Igawa Y, Aizawa N, Niimi A, Yamada Y, Sugihara T, Kamei J, Sato Y, Matsunaga A, Yoshida M, Shinoda Y, Fukuhara H, Nakagawa T, Homma Y, Kume H.

Neurourol Urodyn. 2019 Apr;38(4):1067-1075. doi: 10.1002/nau.23952. Epub 2019 Mar 14.

PMID:
30995359
22.

Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.

Kume H, Homma Y, Shinohara N, Obara W, Kondo T, Kimura G, Fujimoto H, Nonomura N, Hongo F, Sugiyama T, Takahashi M, Kanayama HO, Fukumori T, Eto M.

Jpn J Clin Oncol. 2019 Aug 1;49(8):772-779. doi: 10.1093/jjco/hyz054.

PMID:
30977820
23.

Molecular analysis and literature-based hypothesis of an immunonegative prostate small cell carcinoma causing ectopic ACTH syndrome.

Takeuchi M, Sato J, Manaka K, Tanaka M, Matsui H, Sato Y, Kume H, Fukayama M, Iiri T, Nangaku M, Makita N.

Endocr J. 2019 Jun 28;66(6):547-554. doi: 10.1507/endocrj.EJ18-0563. Epub 2019 Mar 28.

24.

Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report.

Azuma T, Sugihara T, Honda S, Yoshizaki U, Niimi F, Tsuru I, Kume H.

Oncol Lett. 2019 Apr;17(4):4011-4015. doi: 10.3892/ol.2019.10027. Epub 2019 Feb 8.

25.

Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.

Kato H, Senoh M, Honda H, Fukuda T, Tagashira Y, Horiuchi H, Chiba H, Suzuki D, Hosokawa N, Kitazono H, Norisue Y, Kume H, Mori N, Morikawa H, Kashiwagura S, Higuchi A, Kato H, Nakamura M, Ishiguro S, Morita S, Ishikawa H, Watanabe T, Kojima K, Yokomaku I, Bando T, Toimoto K, Moriya K, Kasahara K, Kitada S, Ogawa J, Saito H, Tominaga H, Shimizu Y, Masumoto F, Tadera K, Yoshida J, Kikuchi T, Yoshikawa I, Watanabe T, Honda M, Yokote K, Toyokawa T, Miyazato H, Nakama M, Mahe C, Reske K, Olsen MA, Dubberke ER.

Anaerobe. 2019 Dec;60:102011. doi: 10.1016/j.anaerobe.2019.03.007. Epub 2019 Mar 12.

PMID:
30872073
26.

Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies.

Akiyama Y, Maeda D, Katoh H, Morikawa T, Niimi A, Nomiya A, Sato Y, Kawai T, Goto A, Fujimura T, Fukuhara H, Nakagawa T, Igawa Y, Ishikawa S, Fukayama M, Kume H, Homma Y.

J Urol. 2019 Aug;202(2):290-300. doi: 10.1097/JU.0000000000000234. Epub 2019 Jul 8.

PMID:
30865573
27.

Feasibility of approximate measurement of bladder volume in male patients using the Lilium α-200 portable ultrasound bladder scanner.

Kamei J, Watanabe D, Homma Y, Kume H, Igawa Y.

Low Urin Tract Symptoms. 2019 May;11(3):169-173. doi: 10.1111/luts.12258. Epub 2019 Mar 10.

PMID:
30854772
28.

TRPM8 channel inhibitor AMTB suppresses murine T-cell activation induced by T-cell receptor stimulation, concanavalin A, or external antigen re-stimulation.

Kume H, Tsukimoto M.

Biochem Biophys Res Commun. 2019 Feb 19;509(4):918-924. doi: 10.1016/j.bbrc.2019.01.004. Epub 2019 Jan 11.

PMID:
30642628
29.

RQ-00434739, a novel TRPM8 antagonist, inhibits prostaglandin E2-induced hyperactivity of the primary bladder afferent nerves in rats.

Aizawa N, Ohshiro H, Watanabe S, Kume H, Homma Y, Igawa Y.

Life Sci. 2019 Feb 1;218:89-95. doi: 10.1016/j.lfs.2018.12.031. Epub 2018 Dec 20.

PMID:
30580018
30.

Visceral Mycoses in Autopsied Cases in Japan from 1989 to 2013.

Suzuki Y, Togano T, Ohto H, Kume H.

Med Mycol J. 2018;59(4):E53-E62. doi: 10.3314/mmj.18-00003.

31.

Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography-fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3-5.

Hakozaki Y, Matsushima H, Murata T, Masuda T, Hirai Y, Oda M, Kawauchi N, Yokoyama M, Kume H.

Int J Urol. 2019 Feb;26(2):217-222. doi: 10.1111/iju.13842. Epub 2018 Nov 21.

32.

Aggressive Cancer Behavior of Latent Gleason Pattern 5 in Prostatectomy Specimens.

Fujimura T, Fukuhara H, Yamada Y, Taguchi S, Sugihara T, Niimi A, Nakamura M, Nakagawa T, Igawa Y, Homma Y, Kume H.

Anticancer Res. 2018 Nov;38(11):6529-6535. doi: 10.21873/anticanres.13018.

PMID:
30396982
33.

May perioperative ultrasound-guided pelvic floor muscle training promote early recovery of urinary continence after robot-assisted radical prostatectomy?

Yoshida M, Matsunaga A, Igawa Y, Fujimura T, Shinoda Y, Aizawa N, Sato Y, Kume H, Homma Y, Haga N, Sanada H.

Neurourol Urodyn. 2019 Jan;38(1):158-164. doi: 10.1002/nau.23811. Epub 2018 Oct 30. Erratum in: Neurourol Urodyn. 2019 Feb;38(2):878.

PMID:
30375062
34.

Regional clinical practice variation in urology: Usage example of the Open Data of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.

Sugihara T, Yasunaga H, Matsui H, Kamei J, Fujimura T, Kume H.

Int J Urol. 2019 Feb;26(2):303-305. doi: 10.1111/iju.13840. Epub 2018 Oct 25. No abstract available.

35.

Attenuated lipopolysaccharide-induced inflammatory bladder hypersensitivity in mice deficient of transient receptor potential ankilin1.

Kamei J, Aizawa N, Nakagawa T, Kaneko S, Kume H, Homma Y, Igawa Y.

Sci Rep. 2018 Oct 23;8(1):15622. doi: 10.1038/s41598-018-33967-x.

36.

A rare case of de novo large cell neuroendocrine carcinoma of the prostate with long-term survival after cystoprostatectomy and androgen deprivation.

Miyakawa J, Suzuki M, Endo K, Nose Y, Sato T, Kishida Y, Tamura K, Morinaga S, Kume H, Homma Y.

Urol Case Rep. 2018 Sep 19;21:95-97. doi: 10.1016/j.eucr.2018.09.013. eCollection 2018 Nov. No abstract available.

37.

Androgen-responsive tripartite motif 36 enhances tumor-suppressive effect by regulating apoptosis-related pathway in prostate cancer.

Kimura N, Yamada Y, Takayama KI, Fujimura T, Takahashi S, Kume H, Inoue S.

Cancer Sci. 2018 Dec;109(12):3840-3852. doi: 10.1111/cas.13803. Epub 2018 Oct 30.

38.

The prognostic value of PD-L1 expression in upper tract urothelial carcinoma varies according to platelet count.

Miyama Y, Morikawa T, Miyakawa J, Koyama Y, Kawai T, Kume H, Fukayama M.

Cancer Med. 2018 Sep;7(9):4330-4338. doi: 10.1002/cam4.1686. Epub 2018 Jul 31.

39.

Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.

Azuma T, Sato Y, Ohno T, Azuma M, Kume H.

PLoS One. 2018 Jul 25;13(7):e0199719. doi: 10.1371/journal.pone.0199719. eCollection 2018. Erratum in: PLoS One. 2018 Aug 23;13(8):e0203174.

40.

Association between rectal bleeding and the absolute dose volume of the rectum following image-guided radiotherapy for patients with prostate cancer.

Kotabe K, Nakayama H, Takashi A, Takahashi A, Tajima T, Kume H.

Oncol Lett. 2018 Aug;16(2):2741-2749. doi: 10.3892/ol.2018.8888. Epub 2018 Jun 4.

41.

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase.

Hakozaki Y, Murata T, Yokoyama M, Matsushima H, Ogawa M, Masuda T, Hirai Y, Kume H.

Urol Case Rep. 2018 Jul 7;20:67-69. doi: 10.1016/j.eucr.2018.07.008. eCollection 2018 Sep.

42.

Involvement of Allosteric Effect and KCa Channels in Crosstalk between β₂-Adrenergic and Muscarinic M₂ Receptors in Airway Smooth Muscle.

Kume H, Nishiyama O, Isoya T, Higashimoto Y, Tohda Y, Noda Y.

Int J Mol Sci. 2018 Jul 9;19(7). pii: E1999. doi: 10.3390/ijms19071999.

43.

Prognostic significance of neutrophil-to-lymphocyte ratio in collecting duct carcinoma.

Taguchi S, Fukuhara H, Miyakawa J, Morikawa T, Naito A, Kawai T, Fujimura T, Kume H.

Jpn J Clin Oncol. 2018 Jul 1;48(7):692-694. doi: 10.1093/jjco/hyy076.

PMID:
29846639
44.

Clinical significance of random bladder biopsy in primary T1 bladder cancer.

Otsuka M, Taguchi S, Nakagawa T, Morikawa T, Maekawa S, Miyakawa J, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

Mol Clin Oncol. 2018 May;8(5):665-670. doi: 10.3892/mco.2018.1587. Epub 2018 Mar 8.

45.

Skeletal muscle mass of old Japanese women suffering from walking difficulty in nursing home.

Morishita T, Sato M, Kume H, Sakuma M, Arai H, Katayama T, Katoh S, Sairyo K, Takeda E.

J Med Invest. 2018;65(1.2):122-130. doi: 10.2152/jmi.65.122.

46.

Inhibitory effects of silodosin on the bladder mechanosensitive afferent activities and their relation with bladder myogenic contractions in male rats with bladder outlet obstruction.

Aizawa N, Watanabe D, Fukuhara H, Fujimura T, Kume H, Homma Y, Igawa Y.

Neurourol Urodyn. 2018 Aug;37(6):1897-1903. doi: 10.1002/nau.23547. Epub 2018 Mar 6.

PMID:
29508437
47.

KPR-2579, a novel TRPM8 antagonist, inhibits acetic acid-induced bladder afferent hyperactivity in rats.

Aizawa N, Fujimori Y, Kobayashi JI, Nakanishi O, Hirasawa H, Kume H, Homma Y, Igawa Y.

Neurourol Urodyn. 2018 Jun;37(5):1633-1640. doi: 10.1002/nau.23532. Epub 2018 Feb 21.

PMID:
29464762
48.

Physical activity in daily life in patients with idiopathic pulmonary fibrosis.

Nishiyama O, Yamazaki R, Sano H, Iwanaga T, Higashimoto Y, Kume H, Tohda Y.

Respir Investig. 2018 Jan;56(1):57-63. doi: 10.1016/j.resinv.2017.09.004. Epub 2017 Oct 23.

PMID:
29325683
49.

Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.

Akiyama Y, Niimi A, Nomiya A, Yamada Y, Nakagawa T, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

Neurourol Urodyn. 2018 Apr;37(4):1441-1447. doi: 10.1002/nau.23467. Epub 2018 Jan 9.

PMID:
29315774
50.

Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.

Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

World J Urol. 2018 Feb;36(2):249-256. doi: 10.1007/s00345-017-2141-2. Epub 2017 Nov 28.

PMID:
29185045

Supplemental Content

Support Center